Composition
- Active ingredients
- OXAZEPAM 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- OXAZEPAM 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA015539-008 · Discontinued
- OXAZEPAM 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleThis page
- OXAZEPAM 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA015539-004 · Discontinued
- OXAZEPAM 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA015539-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA015539.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Serax
- Active substance
- oxazepam
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Alpharma US Pharms
- Status
- Discontinued
- FDA approval
- 4 Jun 1965
- Application
- NDA015539-006